GABITRIL is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Carilion Materials Management. The primary component is Tiagabine Hydrochloride.
| Product ID | 68151-4235_7c25748c-ffc7-452a-999a-414101b232d4 | 
| NDC | 68151-4235 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | GABITRIL | 
| Generic Name | Tiagabine Hydrochloride | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2001-04-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020646 | 
| Labeler Name | Carilion Materials Management | 
| Substance Name | TIAGABINE HYDROCHLORIDE | 
| Active Ingredient Strength | 4 mg/1 | 
| Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2018-12-31 | 
| Marketing Start Date | 2010-02-08 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020646 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-08 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| TIAGABINE HYDROCHLORIDE | 4 mg/1 | 
| SPL SET ID: | 72b7f357-8827-4a8b-b55a-01fbce47ae80 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 63459-402 | GABITRIL | Tiagabine Hydrochloride | 
| 68151-4235 | GABITRIL | GABITRIL | 
| 63459-416 | GABITRIL | GABITRIL | 
| 63459-404 | GABITRIL | GABITRIL | 
| 63459-412 | GABITRIL | GABITRIL | 
| 0093-5030 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | 
| 0093-5031 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | 
| 0093-8072 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | 
| 0093-8076 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | 
| 16714-151 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | 
| 16714-152 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | 
| 16714-153 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | 
| 16714-154 | Tiagabine Hydrochloride | Tiagabine Hydrochloride | 
| 52536-350 | tiagabine hydrochloride | tiagabine hydrochloride | 
| 52536-355 | tiagabine hydrochloride | tiagabine hydrochloride | 
| 52536-360 | tiagabine hydrochloride | tiagabine hydrochloride | 
| 52536-365 | tiagabine hydrochloride | tiagabine hydrochloride | 
| 62756-200 | TIAGABINE HYDROCHLORIDE | TIAGABINE HYDROCHLORIDE | 
| 62756-224 | TIAGABINE HYDROCHLORIDE | TIAGABINE HYDROCHLORIDE | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() GABITRIL  76356141  2624880 Dead/Cancelled  | 
        Cephalon, Inc.  2002-01-08  | 
![]() GABITRIL  76330868  not registered Dead/Abandoned  | 
        Cephalon, Inc.  2001-10-29  | 
![]() GABITRIL  75048016  2155299 Live/Registered  | 
        CEPHALON, INC.  1996-01-24  | 
![]() GABITRIL  74425952  not registered Dead/Abandoned  | 
        Abbott Laboratories  1993-08-18  |